John Volpone
Oficial de Recursos Humanos en CTI BIOPHARMA CORP. .
Cargos activos de John Volpone
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
CTI BIOPHARMA CORP. | Oficial de Recursos Humanos | - | - |
Corporate Officer/Principal | - | - |
Historial de carrera de John Volpone
Antiguos cargos conocidos de John Volpone.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Corporate Officer/Principal | - | - |
Formación de John Volpone.
University of Washington | Undergraduate Degree |
Seattle University | Masters Business Admin |
Estadísticas
Internacional
Estados Unidos | 5 |
Operativa
Corporate Officer/Principal | 2 |
Human Resources Officer | 1 |
Undergraduate Degree | 1 |
Sectorial
Health Technology | 3 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
CTI BioPharma Corp.
CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA. | Health Technology |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Health Technology |
- Bolsa de valores
- Insiders
- John Volpone
- Experiencia